Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets

Steroids

Volumn 72, Issue 13, 2007, Pages 875-880

  Li, ShiJun ^a   Li, XiaoYing ^a   Li, Jian ^a   Deng, Xinli ^a   Li, Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Androgen; Oxidative stress; Platelet aggregation; Receptor; Thromboxane A2

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; FLUTAMIDE; HYDROGEN PEROXIDE; THROMBOXANE A2; THROMBOXANE B2;

ANDROGEN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; TESTOSTERONE BLOOD LEVEL; THROMBOCYTE AGGREGATION;

ANDROGENS; ANIMALS; BLOOD PLATELETS; DIHYDROTESTOSTERONE; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PLATELET AGGREGATION; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN; TESTOSTERONE; THROMBOXANE A2;

RATTUS;

EID: 34548636453     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.07.007     Document Type: Article

References (29)

1. Nowak J., Murray J.J., Oates J.A., and FitzGerald G.A. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 76 (1987) 6-14
2. Davì G., Averna M., Catalano I., Barbagallo C., Ganci A., Notarbartolo A., et al. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 85 (1992) 1792-1798
3. Davi G., Catalano I., Averna M., et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322 (1990) 1769-1774
4. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 330 (1994) 1287-1294
5. Ridker P.M. High-sensitivity C-reactive protein. Circulation 103 (2001) 1813-1818
6. Maytin M., Leopold J., and Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep 1 (1999) 156-164
7. Shiozawa Z., Yamada H., Mabuchic C., Hotta T., Saito M., Sobue I., et al. Superior sagital sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol 12 (1982) 578-580
8. Jaillard A.S., Hommel M., and Mallaret M. Venous sinus thrombosis associated with androgens in a healthy young man. Stroke 25 (1994) 212-213
9. Shahidi N.T. A review of the chemistry, biological action and clinical applications of anabolic androgenic steroids. Clin Ther 23 (2001) 1355-1390
10. Li S.J., Li X.Y., Li J., Deng X.L., Li Y., and Cong Y.L. Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation. Thromb Res (2007) Epub ahead of print
11. Gibbons G.H. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Am J Cardiol 79 (1997) 3-8
12. Treasure C.B., Klein J.L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332 (1995) 481-487
13. Born G.V.R., and Cross M.J. The aggregation of blood platelets. J Physiol 168 (1963) 178-195
14. Hornberger W., and Patscheke H. Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets. J Clin Chem Clin Biochem 27 9 (1989) 567-575
15. Iuliano L., Pratico D., Ghiselli A., Bonavita M.S., and Violi F. Superoxide dismutase triggers activation of "primed" platelets. Arch Biochem Biophys 289 1 (1991) 180-183
16. 2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147 6 (2006) 2675-2680
17. Malkin C.J., Pugh P.J., Jones R.D., Jones T.H., and Channer K.S. Testosterone as a protective factor against atherosclerosis immunomodulation and influence upon plaque development and stability. J Endocrinol 178 (2003) 373-380
18. Srikanth V., Malini T., Arunakaran J., Govindarajulu P., and Balasubramanian K. Effects of ethanol treatment on epididymal secretory products and sperm maturation in albino rats. J Pharmacol Exp Ther 288 2 (1999) 509-515
19. Zhou Z.X., Wong C.I., Sar M., and Wilson E.M. The androgen receptor: an overview. Recent Prog Horm Res 49 (1994) 249-274
20. Quigley C.A., DeBellis A., Marschke K.B., ElAwady M.K., Wilson E.M., and French F.S. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 16 (1995) 271-321
21. Salzman E.W., and Ware J.A. Ionized calcium as an intracellular messenger in blood platelets. Prog Hemostasis Thromb 9 (1989) 177-202
22. English K.M., Steeds R.P., Jones T.H., Diver M.J., and Channer K.S. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina-a randomized, double-blind, placebo-controlled study. Circulation 102 (2000) 1906-1911
23. Klokk T.I., Kurys P., Elbi C., Nagaich A.K., Hendarwanto A., Slagsvold T., et al. Ligand specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol 27 5 (2007) 1823-1843
24. Cato A.C., Nestl A., and Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002 138 (2002) 1-11 (Review)
25. 2+ stimulates the binding to androgen receptors in platelets. Steroids 69 11-12 (2004) 767-772
26. Neri R. Pharmacology and phamacokinetics of flutamide. Urology 34 Suppl. 4 (1989) 19-21
27. 2 and prostacyclin generation in the microvasculature of patients with atherosclerosis-effect of low-dose aspirin. Thromb Haemost 61 3 (1989) 374-377
28. Lellouche F., Martinuzzo M., Said P., Maclouf J., and Carreras L.O. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 78 11 (1991) 2894-2899
29. Neichi T., Tomisawa S., Kubodera N., and Uchida Y. Enhancement of PGI2 formation by a new vasodilator, 2-nicotinamidoethyl nitrate in the coupled system of platelets and aortic microsomes. Prostaglandins 19 4 (1980) 577-586